PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection

  • Science. 2023 Oct 6;382(6666):eadg2253. doi: 10.1126/science.adg2253.
Daniel Fisch  1  2 Moritz M Pfleiderer  3 Eleni Anastasakou  3 Gillian M Mackie  4 Fabian Wendt  5  6 Xiangyang Liu  3 Barbara Clough  2 Samuel Lara-Reyna  2 Vesela Encheva  7 Ambrosius P Snijders  7  8 Hironori Bando  9  10 Masahiro Yamamoto  9  10 Andrew D Beggs  11 Jason Mercer  2 Avinash R Shenoy  12  13 Bernd Wollscheid  5  6 Kendle M Maslowski  4  14  15  16 Wojtek P Galej  3 Eva-Maria Frickel  1  2
Affiliations
  • 1. Host-Toxoplasma Interaction Laboratory, The Francis Crick Institute, London, UK.
  • 2. Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, UK.
  • 3. European Molecular Biology Laboratory, 71 Avenue des Martyrs, Grenoble, France.
  • 4. Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, UK.
  • 5. Department of Health Sciences and Technology (D-HEST), ETH Zürich, Institute of Translational Medicine (ITM), Zürich, Switzerland.
  • 6. Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
  • 7. Mass Spectrometry and Proteomics Platform, The Francis Crick Institute, London, UK.
  • 8. Bruker Nederland BV, Leiderdorp, Netherlands.
  • 9. Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
  • 10. Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • 11. Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, UK.
  • 12. MRC Centre for Molecular Bacteriology and Infection, Department of Infectious Disease, Imperial College London, London, UK.
  • 13. Inflammasome Biology Laboratory, The Francis Crick Institute, London, UK.
  • 14. Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston, UK.
  • 15. Cancer Research UK Beatson Institute, Glasgow, UK.
  • 16. School of Cancer Sciences, University of Glasgow, Glasgow, UK.
Abstract

Disruption of cellular activities by pathogen virulence factors can trigger innate immune responses. Interferon-γ (IFN-γ)-inducible antimicrobial factors, such as the guanylate binding proteins (GBPs), promote cell-intrinsic defense by attacking intracellular pathogens and by inducing programmed cell death. Working in human macrophages, we discovered that GBP1 expression in the absence of IFN-γ killed the cells and induced Golgi fragmentation. IFN-γ exposure improved macrophage survival through the activity of the kinase PIM1. PIM1 phosphorylated GBP1, leading to its sequestration by 14-3-3σ, which thereby prevented GBP1 membrane association. During Toxoplasma gondii Infection, the virulence protein TgIST interfered with IFN-γ signaling and depleted PIM1, thereby increasing GBP1 activity. Although infected cells can restrain pathogens in a GBP1-dependent manner, this mechanism can protect uninfected bystander cells. Thus, PIM1 can provide a bait for pathogen virulence factors, guarding the integrity of IFN-γ signaling.